Skip to content
value.today

Pharmazz, Inc.

🇺🇸 Willowbrook, Illinois, USABiotechnologyFounded 2017
Total raised
$30 M
6 rounds on record
Latest round
$10 M
May 2025
First round on record
Jul 2018
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pharmazz, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$10 MNo. 6$10 to $50 million

Pharmazz, Inc.: Raise no. 6, May 2025

Investors in this round

1 investor had bought by the notice of Jun 11, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $25 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director
  • David Costello · Executive Officer
  • Dharminder Marwah · Executive Officer, Director
  • Sunil Gulati · Executive Officer
  • James McDonnell · Director
  • Jane Kiernan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 11, 2025. Read the notice at the SEC.

equity, optionsSEC
Aug 2024$8 MNo. 5$2 to $10 million

Pharmazz, Inc.: Raise no. 5, Aug 2024

Investors in this round

1 investor had bought by the notice of Aug 30, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $15 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director
  • Daniel Stauder · Executive Officer
  • David Costello · Executive Officer
  • Sunil Gulati · Executive Officer
  • Dharminder Marwah · Director
  • James McConnell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, President and CEO. Source: SEC Form D, newest notice filed Aug 30, 2024. Read the notice at the SEC.

optionsSEC
Oct 2022$2 MNo. 4$2 to $10 million

Pharmazz, Inc.: Raise no. 4, Oct 2022

Investors in this round

16 investors had bought by the notice of May 18, 2023: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $7 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director · President, CEO and Director
  • Daniel Stauder · Executive Officer · Chief Investment Officer
  • David Costello · Executive Officer · Vice President
  • Sunil Gulati · Executive Officer · Chief Operating Officer
  • Dharminder Marwah · Director
  • James McDonnell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, President and CEO. Source: SEC Form D, newest notice filed May 18, 2023. Read the notice at the SEC.

debt, optionsSEC
Apr 2021$5 MNo. 3$2 to $10 million

Pharmazz, Inc.: Raise no. 3, Apr 2021

Investors in this round

28 investors had bought by the notice of May 18, 2023: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director · President, CEO and Director
  • Daniel P. Stauder · Executive Officer · Chief Investment Officer
  • David Costello · Executive Officer · Vice President
  • Sunil Gulati · Executive Officer · Chief Operating Officer
  • Dharminder Marwah · Director
  • James McDonnell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, President and CEO. Source: SEC Form D, newest notice filed May 18, 2023. Read the notice at the SEC.

debt, optionsSEC
Feb 2020$1 MNo. 2Under $2 million

Pharmazz, Inc.: Raise no. 2, Feb 2020

Investors in this round

1 investor had bought by the notice of Mar 3, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director · President, CEO, Director
  • Gaylord Toft · Executive Officer · Executive Vice President
  • Sunil Gulati · Executive Officer · Chief Operating Officer
  • Ajit Srimal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, President and CEO. Source: SEC Form D, newest notice filed Mar 3, 2020. Read the notice at the SEC.

equitySEC
Jul 2018$4 MNo. 1$2 to $10 million

Pharmazz, Inc.: Raise no. 1, Jul 2018

Investors in this round

23 investors had bought by the notice of Nov 14, 2019: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anil Gulati · Executive Officer, Director · President, CEO, Director
  • David Costello · Executive Officer · Vice President
  • Gaylord Toft · Executive Officer · Chief Financial Officer
  • Sunil Gulati · Executive Officer · Chief Operating Officer
  • Ajit Srimal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anil Gulati, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 14, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pharmazz, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2025).

    SEC Form D · Jun 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2025

That is all the official record says: Pharmazz, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pharmazz, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pharmazz, Inc.
NameRoleNamed in
Anil GulatiExecutive officerJun 2025
David CostelloExecutive officerJun 2025
Dharminder MarwahExecutive officerJun 2025
Sunil GulatiExecutive officerJun 2025
Daniel StauderExecutive officerAug 2024
Daniel P. StauderChief Investment OfficerMay 2023
Gaylord ToftExecutive Vice PresidentMar 2020
Anil GulatiDirectorJun 2025
Dharminder MarwahDirectorJun 2025
James McDonnellDirectorJun 2025
Jane KiernanDirectorJun 2025
James McConnellDirectorAug 2024
Ajit SrimalDirectorMar 2020